Le Lézard
Classified in: Health, Science and technology
Subjects: Funding, Bond Issue

PerkinElmer Prices Offering of Senior Notes


PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that it has priced an offering of $400.0 million aggregate principal amount of 2.550% Senior Notes due 2031 at an issue price of 99.965% of the principal amount and $400.0 million aggregate principal amount of 3.625% Senior Notes due 2051 at an issue price of 99.999% of the principal amount.

The issuance of the notes is expected to close on March 8, 2021, subject to customary closing conditions. The notes will pay interest on a semi-annual basis.

PerkinElmer plans to use approximately $561 million of the net proceeds of the offering to repay amounts borrowed under its senior unsecured revolving credit facility to fund a portion of the purchase price for its acquisition of Oxford Immunotec Global PLC. PerkinElmer expects to use the remaining net proceeds of the offering to repay at maturity a portion of its outstanding ?300.0 million aggregate principal amount of 0.600% senior notes due 2021.

The joint book-running managers for the offering are J.P. Morgan Securities LLC, BofA Securities, Inc., and Wells Fargo Securities, LLC.

The offering is being made pursuant to an effective registration statement on Form S-3 (including a prospectus) filed with the U.S. Securities and Exchange Commission ("SEC"). Prospective investors should read the prospectus forming a part of that registration statement and the prospectus supplement related to the offering and the other documents that PerkinElmer has filed with the SEC for more complete information about the company and this offering. These documents are available at no charge by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, copies of the prospectus supplement and the accompanying prospectus relating to the offering can be obtained by calling one of the joint book-running managers at the following: J.P. Morgan Securities LLC collect at 1-212-834-4533 or BofA Securities, Inc. toll-free at 1-800-294-1322.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy the notes, nor shall there be any offer, solicitation or sale of the notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $3.8 billion in 2020, has about 14,000 employees serving customers in more than 190 countries, and is a component of the S&P 500 Index.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements about PerkinElmer's intended use of proceeds, including its acquisition of Oxford Immunotec Global PLC. These statements involve a number of risks and uncertainties that could cause actual results to differ materially from currently anticipated results, including risks and uncertainties relating to capital markets conditions and completion of the offering. Additional important factors and information regarding PerkinElmer's business that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the prospectus and preliminary prospectus supplement dated March 4, 2021 related to the offering, which is on file with the SEC and available in the "Investors" section of the Company's website under the heading "SEC Filings," and the documents incorporated by reference into the prospectus and prospectus supplement. While PerkinElmer may elect to update forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so, even if circumstances change and, therefore, you should not rely on these forward-looking statements as representing the Company's views as of any date subsequent to today.


These press releases may also interest you

at 06:50
WEX , a leading financial technology service provider, has signed a multi-year fuel card agreement with Kum & Go. The retailer ranked No. 18 on CSP's (Convenience Store Products) list of Top 202 Convenience Store Chains of 2020 and is continuing a...

at 06:50
MetroNet today announced that funds managed by leading global investment firm KKR will be joining long-time partner, Oak Hill Capital, and management as investors in MetroNet. As part of the transaction, Oak Hill and KKR will each make new...

at 06:45
The "Global Nucleic Acid Isolation and Purification Market - Analysis By Product Type, Application, End-User, By Region, By Country (2021 Edition): Market Insights, Covid -19 Impact, Competition and Forecast (2021-2026)" report has been added to...

at 06:45
On April 20, 2021, Beatrice H. Bassey notified International Game Technology PLC (the "Company") of her intention not to stand for re-election as a member of the Company's Board of Directors. Ms. Bassey will serve out her remaining term and will...

at 06:35
SolarWinds , a leading provider of powerful and affordable IT management software, today announced it has improved its placement on the Completeness of Vision axis, in the Niche Quadrant of the April 2021 Gartner® Magic Quadrant® for Application...

at 06:35
Global Blue, today, announced the launch of Global Blue Ventures, a new entity created to identify, invest in and/or partner with third parties that offer market-leading retail technology solutions. Global Blue Ventures was initiated in 2019, and...



News published on 4 march 2021 at 19:25 and distributed by: